✦ LIBER ✦

Artesunate and sulfadoxine-pyrimethamine combinations for the treatment of uncomplicated Plasmodium falciparum malaria in Uganda: a randomized, double-blind, placebo-controlled trial

✍ Scribed by Gerardo Priotto; Jerome Kabakyenga; Loretxu Pinoges; Ana Ruiz; Therese Eriksson; François Coussement; Tharcise Ngambe; Walter R.J. Taylor; William Perea; Jean-Paul Guthmann; Piero Olliaro; Dominique Legros

Book ID: 108368745
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 724 KB
Volume: 97
Category: Article
ISSN: 0035-9203
DOI: 10.1016/s0035-9203(03)90161-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized safety and tolerability tri

A randomized safety and tolerability trial of artesunate plus sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine alone for the treatment of uncomplicated malaria in Gambian children

✍ J.F. Doherty; A.D. Sadiq; L. Bayo; A. Alloueche; P. Olliaro; P. Milligan; L. von 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 474 KB

Artemisinin derivatives, such as artesunate, have a short half-life and very rapid anti-malarial activity. Theoretically, using such agents in conjunction with well-established anti-malarial drugs such as sulfadoxine-pyrimethamine may reduce the rate of drug resistance. Such a combination has not pr

Efficacy of artesunate plus chloroquine

Efficacy of artesunate plus chloroquine for the treatment of uncomplicated malaria in children in Burkina Faso: a double-blind, randomized, controlled trial

✍ Sodiomon Bienvenu Sirimai; Alfred B. Tiono; Amadou Konaté; Amidou Diarra; France 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 566 KB

A randomized, double-blind study on the

A randomized, double-blind study on the efficacy and safety of a practical three-day regimen with artesunate and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria in Africa

✍ A. Massougbodji; M. Kone; D. Kinde-Gazard; A. Same-Ekobo; N. Cambon; E.A. Muelle 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 630 KB

A randomized double-blind placebo-contro

A randomized double-blind placebo-controlled field trial of ivermectin and albendazole alone and in combination for the treatment of lymphatic filariasis in Ghana

✍ Samuel K. Dunyo; Francis K. Nkrumah; Paul E. Simonsen 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 944 KB

Combination therapy with thymosin α1 and

Combination therapy with thymosin α1 and interferon for the treatment of chronic hepatitis C infection: A randomized, placebo-controlled double-blind trial

✍ Kenneth E. Sherman; Maria Sjogren; Robin L. Creager; Melissa A. Damiano; Stephen 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB 👁 1 views

Hepatitis C is a major cause of liver disease leading to cirrhosis. Although interferon (IFN) is the only approved therapy, treatment is characterized by low response rates and dose-limiting side effects. We evaluated the addition of thymosin ␣1 (TA1), an immunomodulatory peptide, to the standard tr

A multicenter, prospective, randomized,

A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma

✍ Rachel K. Hoyles; Ross W. Ellis; Jessica Wellsbury; Belinda Lees; Pauline Newlan 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 2 views

## Abstract ## Objective The lack of randomized controlled trials (RCTs) in pulmonary fibrosis in systemic sclerosis (SSc) has hampered an evidence‐based approach to treatment. This RCT was undertaken to investigate the effects of intravenous (IV) cyclophosphamide (CYC) followed by azathioprine (A